Phentolamine

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C17H19N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z468598HBV, chemically known as 2-imidazoline, 2-((n-(m-hydroxyphenyl)-p-toluidino)methyl)- but generally known as phentolamine, which bears US NIH Compound Identifier 5775. European Medicines Agency schedules Phentolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09785MIG. The term PHENTOLAMINE is an International Non-Proprietary Name. World Health Organization schedules phentolamine in its Anatomical Therapeutic Chemical (ATC) Classification. PHENTOLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phentolamine under HS 29332910 and SITC 51573. As of Q4 2014, PHENTOLAMINE remains the US FDA Preferred Term for this commodity. Phentolamine bears US NLM identifiers UMLS ID C0031448 and NCI Concept Code C62066. SMILES: OC1CC(N(CC2=NCCN2)C2CCC(CC2)C)CCC1.